Critical review of indications for renal artery stenting: Do randomized trials give the answer?
Authors:
- 7 April 2009
- journal article
- review article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 74 (2) , 251-256
Abstract
Significant renal artery stenosis (RAS) is a well accepted cause of deterioration of arterial hypertension and of renal insufficiency. Just recently, more interest has been focused on the impact of RAS on structural heart disease and patient survival. Technical improvements of diagnostic and interventional endovascular tools have lead to a more widespread use of endoluminal renal artery revascularization and extension of the indications for this type of therapy during the past 2 decades. Since the first renal artery angioplasties performed by Felix Mahler and Andreas Grüntzig, numerous single centre studies have reported the beneficial effect of percutaneous transluminal renal angioplasty, and since the early 1990's stenting of renal artery stenosis caused either by atherosclerosis or fibromuscular dysplasia. However, none of the so far published or presented randomized controlled trials (RCT) could prove a beneficial outcome of RAS revascularization compared with medical management. As a result of these negative trials including the recently presented ASTRAL trial, referrals to endovascular renal artery revascularization went down and moreover, reimbursement of these procedures became a matter of debate. This article summarizes the background and the limitations of the so far published and still ongoing controlled trials. Moreover, we discuss why well‐designed registries might give important insight on the impact of endovascular revascularization of hemodynamically relevant atherosclerotic RAS.Keywords
This publication has 37 references indexed in Scilit:
- Color‐coded duplex ultrasound for diagnosis of renal artery stenosis and as follow‐up examination after revascularizationCatheterization and Cardiovascular Interventions, 2008
- Controversial Treatment of Atherosclerotic Renal Vascular DiseaseHypertension, 2006
- Stent-Supported Angioplasty of Severe Atherosclerotic Renal Artery Stenosis Preserves Renal Function and Improves Blood Pressure Control:Long-term Results From a Prospective Registry of 456 LesionsJournal of Endovascular Therapy, 2004
- Predictors of Improved Renal Function After Percutaneous Stent-Supported Angioplasty of Severe Atherosclerotic Ostial Renal Artery StenosisCirculation, 2003
- Gold coating and restenosis after primary stenting of ostial renal artery stenosisCatheterization and Cardiovascular Interventions, 2003
- Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosisCatheterization and Cardiovascular Interventions, 2003
- Farbduplexsonographische Darstellbarkeit von Nierenarterien und Erkennung hämodynamisch relevanter NierenarterienstenosenUltraschall in der Medizin - European Journal of Ultrasound, 2001
- Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery StenosisHypertension, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990